MONDAY, Feb. 15, 2021 (HealthDay Information) — For folks with questions on COVID-19 vaccines and kids, Johns Hopkins Medication specialists provide solutions.
Whereas vaccinations for adults are underway in the US, scientific trials for the primary U.S. Meals and Drug Administration-authorized COVID-19 vaccines have not but been accomplished for youngsters and youths youthful than 16.
Earlier than that age group can obtain a vaccine, the FDA and U.S. Facilities for Illness Management and Prevention should settle for scientific trial outcomes exhibiting the vaccines are protected and efficient in kids, defined Dr. Aaron Milstone, a professor of pediatrics at Hopkins’ College of Medication, and Dr. Kawsar Talaat, assistant professor on the Bloomberg College of Public Well being, in Baltimore.
Presently, Pfizer’s COVID-19 vaccine has FDA approval to be used in folks 16 and older, whereas youngsters aged 12 to fifteen have been enrolled in scientific trials of the vaccine.
The Moderna vaccine has FDA approval to be used in folks 18 and older, whereas youngsters aged 12 to 17 are being enrolled in trials of the vaccine.
COVID-19 vaccines for youngsters older than 12 years could also be approved by late spring or early summer time, however it could be late 2021 or 2022 earlier than vaccines are approved for these youthful than 12, the docs stated.
When youngsters can truly get vaccinated will rely upon the vaccine provide, the specialists famous in a Hopkins information launch. At present, vaccines are being distributed to teams of individuals primarily based on precedence.
Till kids can get vaccinated, dad and mom ought to defend their youngsters from COVID-19 by persevering with to follow prevention measures, reminiscent of sporting face masks, sustaining protected bodily distance from others and by working towards applicable hand hygiene, Milstone and Talaat suggested.
The American Academy of Pediatrics has extra on COVID-19.
SOURCE: Johns Hopkins Medication, information launch, Feb. 9, 2021